Metagenomi, Inc.
MGX
$1.86
-$0.05-2.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -85.38% | 0.43% | -21.27% | 5.28% | 17.44% |
| Total Depreciation and Amortization | 1.99% | 6.68% | 21.65% | 18.20% | 29.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.91% | -36.85% | 492.91% | 76.96% | 197.55% |
| Change in Net Operating Assets | 61.75% | 79.12% | -253.36% | -80.82% | -104.81% |
| Cash from Operations | 19.23% | 23.48% | -27.60% | -12.25% | -0.83% |
| Capital Expenditure | 80.90% | 68.52% | 80.77% | 46.88% | 78.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 254.89% | 126.66% | -53.70% | -109.90% | 20.54% |
| Cash from Investing | 246.30% | 126.10% | -52.92% | -111.77% | 30.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 91.83% | -100.09% | 100.00% | 74.24% | -5,110.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.33% | 104.75% | -94.14% | -171.77% | 7.74% |